Dr. Clayton W. Snell, A Deep Dive Into Epidiolex

June 2021

Dr. Clayton W. Snell is the Senior Medical Science Liaison at Greenwich Biosciences (now part of Jazz Pharmaceuticals) and holds a Doctor of Pharmacy (PharmD) from the University of the Sciences in Philadelphia and possesses experience in professional medical affairs, healthcare services, and a demonstrated history in the pharmaceutical industry.

Previous Webinars

Travis Higginbotham

March 18 at 11:00 AM (MST)

Turning Science into Cash Flow. Crop production performance and ROI analysis driven by crop science.

Travis Higginbitham is the Founder & CEO of Due Diligence Horticulture (DDH). He is a horticultural and operations executive with deep experience leading controlled-environment agriculture, cannabis, and ornamental production businesses through innovation, growth, transition, and turnaround. Mr. […]

Read More »

Dr. Yan Wang

12 March, 1:00 PM MST

Real-time and long-term effects of medical marijuana on older adults with chronic pain: Early findings from a prospective cohort study.

 

Yan Wang is an Associate Professor of Epidemiology at the University of Florida (UF). Her research interests focus on leveraging advanced technologies and methods (e.g., wearable sensors, ecological momentary assessment/EMA) to improve […]

Read More »

Igor Grant, M.D. and Thomas Marcotte, Ph.D.

Thursday, February 12th at 1:00 PM MST

The UC San Diego Center for Medicinal Cannabis Research: Some Findings

Igor Grant, MD is Distinguished Professor, and Director of the Center for Medicinal Cannabis Research (CMCR) at the University of California San Diego (UCSD). Established in 2000, the CMCR has been at the forefront of advancing science and policy […]

Read More »

Almut Winterstein, PhD.

Jan 8, 2026 01:00 PM Mountain Time

Clinical research priorities gleaned real-world use patterns: the MEdical Marijuana Outcomes Research repositorY (MEMORY)

Almut Winterstein is Distinguished Professor and the Dr. Robert and Barbara Crisafi Chair for Medication Safety in the Department of Pharmaceutical Outcomes and Policy and in the Department of Epidemiology, and the founding Director of the […]

Read More »

Carolyn Baglole, PhD,

December, 11, 2025 1:00 PM MST

Multi-omics dissection of the molecular and pharmacological effects of inhaled cannabis

Professor Carolyn Baglole earned her Bachelor of Science and Master of Science degrees from the University of Prince Edward Island, followed by a PhD in Physiology and Pharmacology from the University of Calgary. Dr. Baglole then completed postdoctoral training at […]

Read More »

Margaret Haney, PhD

Nov 13, 2025 01:00 PM MST

Cannabis Misuse and Therapeutic Potential: Placebo-controlled Laboratory Studies

Dr. Margaret (Meg) Haney is a Professor of Neurobiology (in Psychiatry) at the Columbia University Irving Medical Center. As the Director of the Cannabis Research Laboratory and of the Substance Use Research Center in the Division of Substance Use Disorders, Dr. Haney is […]

Read More »